# A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)

> **NCT01154374** · PHASE2 · COMPLETED · sponsor: **Skingenix, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DRUG:** MEBO Wound Ointment
- **PROCEDURE:** Standard of Care (sterile saline moistened gauze)

## Key facts

- **NCT ID:** NCT01154374
- **Lead sponsor:** Skingenix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154374, "A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01154374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*